-
1
Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights...
Published 2024-12-01Subjects: “…Delamanid…”
Get full text
Article -
2
Effect of delamanid on interim outcomes of bacteriological conversion amongst pediatric drug resistant tuberculosis cases in India
Published 2024-01-01Subjects: Get full text
Article -
3
Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs
Published 2024-08-01Subjects: Get full text
Article -
4
Drug resistance to delamanid was detected in susceptible tuberculosis patient in Russia
Published 2024-12-01Subjects: Get full text
Article -
5
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid
Published 2020-09-01Subjects: Get full text
Article -
6
The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
Published 2021-01-01Subjects: Get full text
Article -
7
Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis
Published 2024-12-01Subjects: Get full text
Article -
8
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
Published 2019-08-01Subjects: Get full text
Article -
9
Rezultatele tratamentului tuberculozei multidrogrezistente cu utilizarea bedaquiline şi delamanid
Published 2021-05-01Subjects: Get full text
Article -
10
Comparative safety of bedaquiline and delamanid in patients with multidrug resistant tuberculosis: A nationwide retrospective cohort study
Published 2023-08-01Subjects: Get full text
Article -
11
New regimens and new medications in the treatment of tuberculosis: keeping step?
Published 2021-04-01Subjects: Get full text
Article -
12
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
Published 2022-11-01Subjects: Get full text
Article -
13
Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance Mycobacterium tuberculosis in Shanghai, China
Published 2023-12-01Subjects: Get full text
Article -
14
Experience of Using Delamanid in the Treatment of Multiple Drug Resistant Tuberculosis
Published 2024-10-01Subjects: Get full text
Article -
15
Effectiveness and safety of regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
Published 2024-04-01Subjects: Get full text
Article -
16
Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review
Published 2023-01-01Subjects: Get full text
Article -
17
-
18
-
19
Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
Published 2022-01-01Subjects: Get full text
Article -
20